Diagonal Bio AB Financial Overview
Diagonal Bio AB's market cap is currently €604.06K. The company's EPS TTM is €-0.000092121; its P/E ratio is ―; Diagonal Bio AB is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
